Cargando…
Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?
A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chlo...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153521/ https://www.ncbi.nlm.nih.gov/pubmed/32315948 http://dx.doi.org/10.1016/j.dsx.2020.04.014 |
_version_ | 1783521668368433152 |
---|---|
author | Baretić, Maja |
author_facet | Baretić, Maja |
author_sort | Baretić, Maja |
collection | PubMed |
description | A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery. |
format | Online Article Text |
id | pubmed-7153521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Diabetes India. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71535212020-04-14 Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? Baretić, Maja Diabetes Metab Syndr Article A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery. Diabetes India. Published by Elsevier Ltd. 2020 2020-04-13 /pmc/articles/PMC7153521/ /pubmed/32315948 http://dx.doi.org/10.1016/j.dsx.2020.04.014 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Baretić, Maja Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? |
title | Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? |
title_full | Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? |
title_fullStr | Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? |
title_full_unstemmed | Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? |
title_short | Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? |
title_sort | case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153521/ https://www.ncbi.nlm.nih.gov/pubmed/32315948 http://dx.doi.org/10.1016/j.dsx.2020.04.014 |
work_keys_str_mv | AT bareticmaja casereportofchloroquinetherapyandhypoglycaemiaintype1diabeteswhatshouldwehaveinmindduringthecovid19pandemic |